Teva Pharmaceutical's Q4 2024 results were strong, but 2025 guidance underwhelmed, causing a sharp stock sell-off. See why I ...

We assign Teva a Morningstar Uncertainty Rating of High, which largely reflects our quantitative analysis of the firm, based on the return ranges used by our star rating system, as well as our ...

MSFT, ORCL, and CRM lead the 9 biggest software companies list Nathan Reiff has been writing expert articles and news about financial topics such as investing and trading, cryptocurrency ...

Bureau of Competition published four reports on pharmaceutical patent settlement agreements filed under the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) for fiscal ...

The active pharmaceutical ingredient includes vitamin B5 and the original B5. The polymeric materials include polybutylene succinate and Polyvinyl butyral products. The company was founded on ...

Senores Pharmaceuticals Ltd on Thursday said it has secured nearly Rs 261 crore from anchor investors. The Rs 582-crore IPO will conclude on December 24. The IPO has a price range of Rs 372-391 per ...

Many healthcare companies are also highly dependent on Medicare reimbursement levels. Recent changes to Medicare allow the program to negotiate prices for some high-cost drugs with pharmaceutical ...

The facility aims to advance AI in drug discovery, clinical trials, and patient care. The company plans to launch its Dengue vaccine in India by 2026 and expand its focus on inflammation, oncology, ...

Yet, the cost of those innovations places new drugs out of reach for many patients and significantly burdens others. Are pharmaceutical companies earning too much? Deciding whether pharmaceutical ...

There are a lot of them and they're just quite competitive.” Li’s experience is illustrative of a trend that could pressure biotech companies in the U.S. and alter their drug development strategies.

His laboratory at the University of Washington announced on Wednesday that its disruptive artificial intelligence programs, for which Baker won the Nobel Prize, have succeeded for the first time in ...